Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial.

Ducret A, James I, Wilson S, Feilke M, Tebbe A, Dybowski N, Elschenbroich S, Klammer M, Blackler A, Liao WL, Tian Y, Friess T, Bossenmaier B, Dietmann G, Schaab C, Hembrough T, Ceppi M.

PLoS One. 2019 Mar 21;14(3):e0213892. doi: 10.1371/journal.pone.0213892. eCollection 2019.

2.

Compartment-resolved Proteomic Analysis of Mouse Aorta during Atherosclerotic Plaque Formation Reveals Osteoclast-specific Protein Expression.

Wierer M, Prestel M, Schiller HB, Yan G, Schaab C, Azghandi S, Werner J, Kessler T, Malik R, Murgia M, Aherrahrou Z, Schunkert H, Dichgans M, Mann M.

Mol Cell Proteomics. 2018 Feb;17(2):321-334. doi: 10.1074/mcp.RA117.000315. Epub 2017 Dec 4.

3.

Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells.

Roolf C, Dybowski N, Sekora A, Mueller S, Knuebel G, Tebbe A, Murua Escobar H, Godl K, Junghanss C, Schaab C.

Mol Cell Proteomics. 2017 Jul;16(7):1365-1376. doi: 10.1074/mcp.M117.067462. Epub 2017 Apr 27.

4.

Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models.

Beaumont V, Zhong S, Lin H, Xu W, Bradaia A, Steidl E, Gleyzes M, Wadel K, Buisson B, Padovan-Neto FE, Chakroborty S, Ward KM, Harms JF, Beltran J, Kwan M, Ghavami A, Häggkvist J, Tóth M, Halldin C, Varrone A, Schaab C, Dybowski JN, Elschenbroich S, Lehtimäki K, Heikkinen T, Park L, Rosinski J, Mrzljak L, Lavery D, West AR, Schmidt CJ, Zaleska MM, Munoz-Sanjuan I.

Neuron. 2016 Dec 21;92(6):1220-1237. doi: 10.1016/j.neuron.2016.10.064. Epub 2016 Dec 1.

5.

Structure-guided development of heterodimer-selective GPCR ligands.

Hübner H, Schellhorn T, Gienger M, Schaab C, Kaindl J, Leeb L, Clark T, Möller D, Gmeiner P.

Nat Commun. 2016 Jul 26;7:12298. doi: 10.1038/ncomms12298.

6.

Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice.

Langfelder P, Cantle JP, Chatzopoulou D, Wang N, Gao F, Al-Ramahi I, Lu XH, Ramos EM, El-Zein K, Zhao Y, Deverasetty S, Tebbe A, Schaab C, Lavery DJ, Howland D, Kwak S, Botas J, Aaronson JS, Rosinski J, Coppola G, Horvath S, Yang XW.

Nat Neurosci. 2016 Apr;19(4):623-33. doi: 10.1038/nn.4256. Epub 2016 Feb 22.

7.

Systematic evaluation of label-free and super-SILAC quantification for proteome expression analysis.

Tebbe A, Klammer M, Sighart S, Schaab C, Daub H.

Rapid Commun Mass Spectrom. 2015 May 15;29(9):795-801. doi: 10.1002/rcm.7160.

PMID:
26377007
8.

Comparative proteome analysis across non-small cell lung cancer cell lines.

Grundner-Culemann K, Dybowski JN, Klammer M, Tebbe A, Schaab C, Daub H.

J Proteomics. 2016 Jan 1;130:1-10. doi: 10.1016/j.jprot.2015.09.003. Epub 2015 Sep 8.

PMID:
26361996
9.

Time- and compartment-resolved proteome profiling of the extracellular niche in lung injury and repair.

Schiller HB, Fernandez IE, Burgstaller G, Schaab C, Scheltema RA, Schwarzmayr T, Strom TM, Eickelberg O, Mann M.

Mol Syst Biol. 2015 Jul 14;11(7):819. doi: 10.15252/msb.20156123.

10.

Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib.

Klammer M, Dybowski JN, Hoffmann D, Schaab C.

PLoS One. 2015 Jun 17;10(6):e0128542. doi: 10.1371/journal.pone.0128542. eCollection 2015.

11.

Structure-based evolution of subtype-selective neurotensin receptor ligands.

Schaab C, Kling RC, Einsiedel J, Hübner H, Clark T, Seebach D, Gmeiner P.

ChemistryOpen. 2014 Oct;3(5):206-18. doi: 10.1002/open.201402031. Epub 2014 Sep 23.

12.

Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling.

Sharma K, D'Souza RC, Tyanova S, Schaab C, Wiśniewski JR, Cox J, Mann M.

Cell Rep. 2014 Sep 11;8(5):1583-94. doi: 10.1016/j.celrep.2014.07.036. Epub 2014 Aug 21.

13.

Identification of significant features by the Global Mean Rank test.

Klammer M, Dybowski JN, Hoffmann D, Schaab C.

PLoS One. 2014 Aug 13;9(8):e104504. doi: 10.1371/journal.pone.0104504. eCollection 2014.

14.

Beyond the proteome: Mass Spectrometry Special Interest Group (MS-SIG) at ISMB/ECCB 2013.

MS-SIG 2013 Organizers, Ryu SY, Payne SH, Schaab C, Xiao W.

Bioinformatics. 2014 Jul 15;30(14):2089-90. doi: 10.1093/bioinformatics/btu116. Epub 2014 Mar 3. No abstract available.

15.

Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib.

Schaab C, Oppermann FS, Klammer M, Pfeifer H, Tebbe A, Oellerich T, Krauter J, Levis M, Perl AE, Daub H, Steffen B, Godl K, Serve H.

Leukemia. 2014 Mar;28(3):716-9. doi: 10.1038/leu.2013.347. Epub 2013 Nov 19. No abstract available.

16.

Delayed times to tissue fixation result in unpredictable global phosphoproteome changes.

Gündisch S, Grundner-Culemann K, Wolff C, Schott C, Reischauer B, Machatti M, Groelz D, Schaab C, Tebbe A, Becker KF.

J Proteome Res. 2013 Oct 4;12(10):4424-34. doi: 10.1021/pr400451z. Epub 2013 Sep 17.

PMID:
23984901
17.

Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer.

Oppermann FS, Klammer M, Bobe C, Cox J, Schaab C, Tebbe A, Daub H.

J Proteome Res. 2013 Sep 6;12(9):4089-100. doi: 10.1021/pr400417g. Epub 2013 Aug 16.

PMID:
23898821
18.

A SILAC-based approach identifies substrates of caspase-dependent cleavage upon TRAIL-induced apoptosis.

Stoehr G, Schaab C, Graumann J, Mann M.

Mol Cell Proteomics. 2013 May;12(5):1436-50. doi: 10.1074/mcp.M112.024679. Epub 2013 Jan 13.

19.

Proteome-wide analysis of temporal phosphorylation dynamics in lysophosphatidic acid-induced signaling.

Mäusbacher N, Schreiber TB, Machatti M, Schaab C, Daub H.

Proteomics. 2012 Dec;12(23-24):3485-98. doi: 10.1002/pmic.201200172. Epub 2012 Nov 22.

PMID:
23090842
20.

Global quantitative phosphoproteome analysis of human tumor xenografts treated with a CD44 antagonist.

Weigand S, Herting F, Maisel D, Nopora A, Voss E, Schaab C, Klammer M, Tebbe A.

Cancer Res. 2012 Sep 1;72(17):4329-39. doi: 10.1158/0008-5472.CAN-12-0136. Epub 2012 Jul 9.

21.

Phosphosignature predicts dasatinib response in non-small cell lung cancer.

Klammer M, Kaminski M, Zedler A, Oppermann F, Blencke S, Marx S, Müller S, Tebbe A, Godl K, Schaab C.

Mol Cell Proteomics. 2012 Sep;11(9):651-68. doi: 10.1074/mcp.M111.016410. Epub 2012 May 21.

22.

Analysis of high accuracy, quantitative proteomics data in the MaxQB database.

Schaab C, Geiger T, Stoehr G, Cox J, Mann M.

Mol Cell Proteomics. 2012 Mar;11(3):M111.014068. doi: 10.1074/mcp.M111.014068. Epub 2012 Feb 2.

23.

Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins.

Geiger T, Wehner A, Schaab C, Cox J, Mann M.

Mol Cell Proteomics. 2012 Mar;11(3):M111.014050. doi: 10.1074/mcp.M111.014050. Epub 2012 Jan 25.

24.

Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma.

Conradt L, Godl K, Schaab C, Tebbe A, Eser S, Diersch S, Michalski CW, Kleeff J, Schnieke A, Schmid RM, Saur D, Schneider G.

Neoplasia. 2011 Nov;13(11):1026-34.

25.

Analysis of phosphoproteomics data.

Schaab C.

Methods Mol Biol. 2011;696:41-57. doi: 10.1007/978-1-60761-987-1_3.

PMID:
21063940
26.

Identifying differentially regulated subnetworks from phosphoproteomic data.

Klammer M, Godl K, Tebbe A, Schaab C.

BMC Bioinformatics. 2010 Jun 28;11:351. doi: 10.1186/1471-2105-11-351.

27.

Probing teichoic acid genetics with bioactive molecules reveals new interactions among diverse processes in bacterial cell wall biogenesis.

D'Elia MA, Millar KE, Bhavsar AP, Tomljenovic AM, Hutter B, Schaab C, Moreno-Hagelsieb G, Brown ED.

Chem Biol. 2009 May 29;16(5):548-56. doi: 10.1016/j.chembiol.2009.04.009.

28.

Computed virtual chromoendoscopy versus standard colonoscopy with targeted indigocarmine chromoscopy: a randomised multicentre trial.

Pohl J, Lotterer E, Balzer C, Sackmann M, Schmidt KD, Gossner L, Schaab C, Frieling T, Medve M, Mayer G, Nguyen-Tat M, Ell C.

Gut. 2009 Jan;58(1):73-8. doi: 10.1136/gut.2008.153601. Epub 2008 Oct 6.

PMID:
18838485
29.

Prediction of mechanisms of action of antibacterial compounds by gene expression profiling.

Hutter B, Schaab C, Albrecht S, Borgmann M, Brunner NA, Freiberg C, Ziegelbauer K, Rock CO, Ivanov I, Loferer H.

Antimicrob Agents Chemother. 2004 Aug;48(8):2838-44.

30.

Panel of Bacillus subtilis reporter strains indicative of various modes of action.

Hutter B, Fischer C, Jacobi A, Schaab C, Loferer H.

Antimicrob Agents Chemother. 2004 Jul;48(7):2588-94.

31.

Improving DNA array data quality by minimising 'neighbourhood' effects.

Machl AW, Schaab C, Ivanov I.

Nucleic Acids Res. 2002 Nov 15;30(22):e127.

32.

DNA microarray technology and antimicrobial drug discovery.

Ivanov I, Schaab C, Planitzer S, Teichmann U, Machl A, Theml S, Meier-Ewert S, Seizinger B, Loferer H.

Pharmacogenomics. 2000 May;1(2):169-78. Review.

PMID:
11256588
33.

Concordance of creatine kinase-MB activity and mass.

Eisenberg PR, Shaw D, Schaab C, Jaffe AS.

Clin Chem. 1989 Mar;35(3):440-3.

34.

Significance of Doppler-detected mitral regurgitation in acute myocardial infarction.

Barzilai B, Gessler C Jr, Pérez JE, Schaab C, Jaffe AS.

Am J Cardiol. 1988 Feb 1;61(4):220-3.

PMID:
3341197
35.
36.

[Activation and inactivation of citrate lyase during growth of Rhodopseudomonas gelatinosa in citrate medium].

Giffhorn F, Beuscher N, Schaab C, Gottschalk G.

Hoppe Seylers Z Physiol Chem. 1972 Oct;353(10):1518. German. No abstract available.

PMID:
4649786
37.

[Dependency of depth acuity upon age].

Monje M, Schaab C.

Pflugers Arch. 1969;312(1):R144. German. No abstract available.

PMID:
5390203

Supplemental Content

Loading ...
Support Center